Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,233 | 21,726 | 19,844 | 25,751 | 34,130 |
| Marketable Securities | 133,786 | 123,479 | 134,442 | 139,721 | 69,892 |
| Receivables | 18,878 | 15,722 | 13,100 | 8,631 | 78,508 |
| Income taxes - deferred | 1,581 | 1,447 | 1,757 | 1,451 | 1,348 |
| TOTAL | $209,021 | $170,641 | $172,640 | $177,784 | $185,096 |
| Non-Current Assets | |||||
| PPE Net | 7,872 | 5,886 | 2,582 | 2,295 | 1,922 |
| Investments And Advances | 56,618 | 64,238 | 57,657 | 61,330 | 23,568 |
| Other Non-Current Assets | 4,868 | 5,248 | 4,895 | 4,475 | 4,841 |
| TOTAL | $69,358 | $75,372 | $65,134 | $68,100 | $30,331 |
| Total Assets | $278,379 | $246,013 | $237,774 | $245,884 | $215,427 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,767 | 1,543 | 1,614 | 2,343 | 567 |
| Accrued Expenses | 3,165 | 3,962 | 3,469 | 2,910 | 2,403 |
| TOTAL | $10,872 | $6,704 | $7,312 | $19,790 | $19,866 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,228 | 3,152 | 2,180 | 1,879 | 1,848 |
| TOTAL | $3,228 | $3,152 | $2,180 | $1,879 | $1,848 |
| Total Liabilities | $14,100 | $9,856 | $9,492 | $21,669 | $21,714 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,925 | 18,795 | 18,714 | 18,692 | 18,680 |
| Common Shares | 188 | 187 | 189 | 189 | 188 |
| Retained earnings | 32,169 | 5,980 | 168 | -2,250 | -31,003 |
| Other shareholders' equity | -189 | 33 | -76 | -19 | -94 |
| TOTAL | $264,279 | $236,157 | $228,282 | $224,215 | $193,713 |
| Total Liabilities And Equity | $278,379 | $246,013 | $237,774 | $245,884 | $215,427 |